Novo Nordisk is gearing up to submit its rare blood disorder drug to the FDA after the former Forma Therapeutics asset ...
The open-label, multi-center Phase â…¡ clinical study is led by Professor Shen Lin of Beijing Cancer Hospital and is being conducted across multiple hospitals in China. The trial aims to evaluate the ...
MedPage Today on MSN
Next-Generation KRAS G12C Inhibitor Shows 'Robust' Efficacy in Advanced Lung Cancer
Responses observed in patients with and without previous exposure to other KRAS G12C inhib ...
Bloom Energy (NYSE:BE) stock is up 14% in early trading today, and Oracle (NYSE:ORCL | ORCL Price Prediction) stock is up 7%, after the two companies announced an expanded partnership to deploy up to ...
The company best known for its yellow heavy machinery is emerging as a leader providing products and solutions to world's ...
Mount Pleasant has become the epicenter of a landmark legal battle against social media giants — one many are comparing to ...
Mike Bloomberg announced an additional $350 million commitment toward road safety against what's been the leading cause of ...
Some outdoor spots in Colorado do not just catch your eye, they completely hijack your conversation and leave you pointing at ...
Issued on behalf of Starfighters Space, Inc.Companies mentioned in this commentary include: Starfighters Space, Inc. (NYSE American: FJET), ...
A legion of young fans propelled the singer D4vd to viral fame. Now that he’s been charged with the murder of 14-year-old ...
Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow's standard of care to cure cancer and infectious diseases, will release groundbreaking new data at ...
Laureates to be Celebrated Tonight at Breakthrough Prize Ceremony in Los Angeles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results